Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Erbai Zhitong Granules is a Traditional Chinese Medicine (TCM) candidate developed by Yingkerui (Tianjin) Innovative Pharmaceutical Research for the treatment of functional abdominal pain in children. It is specifically indicated for Cold Accumulation Abdominal Pain Syndrome (寒积腹痛证). The drug is currently being evaluated in a Phase II randomized, double-blind, parallel-controlled clinical trial (CTR20254381) to assess its efficacy and safety. As a granule formulation, it is designed for oral administration and likely works through the synergistic effects of its herbal components to warm the middle burner and alleviate abdominal pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiao'er Erbai Zhitong Granules.